Using Bayh-Dole For Cancer Drug March-In Rights Is Wrong
Sen. Elizabeth Warren, D-Mass., recently urged the Biden administration to reduce the price of a prostate cancer medicine, Xtandi, by seizing the developer's patent rights and licensing them to generic drug...To view the full article, register now.
Already a subscriber? Click here to view full article